Dacomitinib
About
Therapy type: Targeted therapy
Therapy strategy: EGFR inhibition
Mappings
NCI Thesaurus: Dacomitinib (coding:ncit:C53398)
RxNorm: dacomitinib (coding:rxcui:2058849, coding:omop:35200803)
Therapeutic response
Precision oncology relationships for therapeutic response involving this therapy.
Organizations
Biomarkers
Cancer types
Therapies
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| FDA (2) | EGFR Exon 19 (Deletion) | Non-Small Cell Lung Cancer | Dacomitinib | |
| FDA (2) | EGFR p.L858R | Non-Small Cell Lung Cancer | Dacomitinib | |
| EMA (1) | EGFR activating variants | Non-Small Cell Lung Cancer | Dacomitinib |